Publications by the researcher in collaboration with Alvaro Janda (2)

2020

  1. Model-Informed Dose Selection for Xentuzumab, a Dual Insulin-Like Growth Factor-I/II—Neutralizing Antibody

    Clinical Pharmacology and Therapeutics, Vol. 107, Núm. 3, pp. 597-606